Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mayer

Showing results (1-10 of 312) with videos related to

Pageof 32
Sort By:
Die Quintessenz|January 1, 1981
[Functional orthodontics with special reference to various changes in U-bow activators (I)]N Mayer
JACEP|July 1, 1978
The Baron revisited: a case reportN Mayer
Die Quintessenz|February 1, 1981
[Functional orthodontics with special reference to various changes in U-bow activators (II)]P N Mayer
Die Quintessenz Der Zahntechnik|January 1, 1983
[Functional improvement of the open U-bow activator]P N Mayer
Die Quintessenz|February 1, 1982
[Late-occurring orthodontic cases and their therapy]P N Mayer
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|April 12, 2006
Radiation therapy for canine mast cell tumorsMonique N Mayer
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|January 26, 2026
Radiotheranostics in veterinary oncologyMonique N Mayer
Current Atherosclerosis Reports|June 8, 2001
Botulinum toxin for the management of muscle overactivity and spasticity after strokeA Esquenazi, N Mayer
Biochemical Pharmacology|October 1, 1990
Labeling of rat heart muscarinic receptors using the new M2 selective antagonist [3H]AF-DX 384M Entzeroth, N Mayer
Journal of Receptor Research|January 1, 1991
The binding of [3H]AF-DX 384 to rat ileal smooth muscle muscarinic receptorsM Entzeroth, N Mayer
Pageof 32

Showing results (1-10 of 312) with videos related to

Sort By:
Pageof 32
Die Quintessenz|January 1, 1981
[Functional orthodontics with special reference to various changes in U-bow activators (I)]N Mayer
JACEP|July 1, 1978
The Baron revisited: a case reportN Mayer
Die Quintessenz|February 1, 1981
[Functional orthodontics with special reference to various changes in U-bow activators (II)]P N Mayer
Die Quintessenz Der Zahntechnik|January 1, 1983
[Functional improvement of the open U-bow activator]P N Mayer
Die Quintessenz|February 1, 1982
[Late-occurring orthodontic cases and their therapy]P N Mayer
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|April 12, 2006
Radiation therapy for canine mast cell tumorsMonique N Mayer
The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|January 26, 2026
Radiotheranostics in veterinary oncologyMonique N Mayer
Current Atherosclerosis Reports|June 8, 2001
Botulinum toxin for the management of muscle overactivity and spasticity after strokeA Esquenazi, N Mayer
Biochemical Pharmacology|October 1, 1990
Labeling of rat heart muscarinic receptors using the new M2 selective antagonist [3H]AF-DX 384M Entzeroth, N Mayer
Journal of Receptor Research|January 1, 1991
The binding of [3H]AF-DX 384 to rat ileal smooth muscle muscarinic receptorsM Entzeroth, N Mayer
Pageof 32